Pure Global

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer - Trial NCT00312013

Access comprehensive clinical trial information for NCT00312013 through Pure Global AI's free database. This Phase 3 trial is sponsored by GlaxoSmithKline and is currently Completed. The study focuses on Thrombosis, Venous. Target enrollment is 503 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT00312013
Phase 3
Completed
drug
Trial Details
ClinicalTrials.gov • NCT00312013
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
A Randomized, Controlled Trial to Evaluate the Effects of Nadroparin on Survival and Disease Progression in Patients With Advanced Malignancies of the Lung, Pancreas, or Prostate

Study Focus

Thrombosis, Venous

Nadroparin

Interventional

drug

Sponsor & Location

GlaxoSmithKline

Aalst,Antwerpen,Brasschaat,Bruxelles,Bruxelles,Liège,Roeselare,Toronto,Brno,Praha 2,Praha 5,Praha 5,Praha 8,Pribram,Bethune Cedex,Clermont Ferrand,Lille,Lyon,Marseille,Paris Cedex 13,Paris Cedex 15,Pa, Belgium,Canada,Czech,France,Germany,Hungary,Italy,Netherlands,Poland,Russian Federation,Slovenia

Timeline & Enrollment

Phase 3

May 01, 2006

Jul 01, 2009

503 participants

Primary Outcome

Death due to all causes at study end (patients will be followed until at least Week 46 after randomization).

Summary

This study will evaluate the effects of nadroparin on survival and disease progression in
 patients with hormone-refractory prostate cancer (HRPC), locally advanced pancreatic cancer
 or non-small-cell lung carcinoma (NSCLC).

ICD-10 Classifications

Other venous embolism and thrombosis
Embolism and thrombosis of unspecified vein
Embolism and thrombosis of other specified veins
Perianal venous thrombosis
Arterial embolism and thrombosis

Data Source

ClinicalTrials.gov

NCT00312013

Non-Device Trial